Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 Nov 6;3(4):143-55.
doi: 10.5527/wjn.v3.i4.143.

Why do young people with chronic kidney disease die early?

Affiliations
Review

Why do young people with chronic kidney disease die early?

Shankar Kumar et al. World J Nephrol. .

Abstract

Cardiovascular disease poses the greatest risk of premature death seen among patients with chronic kidney disease (CKD). Up to 50% of mortality risk in the dialysis population is attributable to cardiovascular disease and the largest relative excess mortality is observed in younger patients. In early CKD, occlusive thrombotic coronary disease is common, but those who survive to reach end-stage renal failure requiring dialysis are more prone to sudden death attributable mostly to sudden arrhythmic events and heart failure related to left ventricular hypertrophy, coronary vascular calcification and electrolyte disturbances. In this review, we discuss the basis of the interaction of traditional risk factors for cardiovascular disease with various pathological processes such as endothelial dysfunction, oxidative stress, low grade chronic inflammation, neurohormonal changes and vascular calcification and stiffness which account for the structural and functional cardiac changes that predispose to excess morbidity and mortality in young people with CKD.

Keywords: Cardiorenal syndrome; Cardiovascular mortality; Chronic kidney disease; Endothelial dysfunction; Vascular calcification and stiffness.

PubMed Disclaimer

Figures

Figure 1
Figure 1
All-cause mortality and its relationship to worsening chronic kidney disease. After Go AS 2004[1].
Figure 2
Figure 2
Cardiovascular event rates according to chronic kidney disease stage. After Go AS 2004[1].
Figure 3
Figure 3
The physiological roles of nitric oxide on endothelial function.
Figure 4
Figure 4
Microalbuminuria as a risk factor for death in type 2 diabetes. Reproduced from Schmitz et al[49], 1988.
Figure 5
Figure 5
Maturation of high-density lipoprotein and the protective effect of apoA-I mimetic peptide 4F. (Apo)A-I: Apolipoprotein A-I; ABCG1: Adenosine triphosphate–binding cassette transporter G-1 protein; LCAT: Lecithin–cholesterol acyltransferase; SR-B1: Scavenger receptor B1; PON1: Paraoxonase-1; LRP: Lipoprotein-like receptor; VEC: Vascular endothelial cells; MCP-1: Monocyte chemoattractant protein-1; HDL: High-density lipoprotein. After Kaysen[74], 2009.
Figure 6
Figure 6
Premature death related to heart failure in haemodialysis. After Harnett et al[81], 1995.
Figure 7
Figure 7
Interplay between calcium, phosphate, calcitriol and Fibroblast growth factor-23 in chronic kidney disease. FGF: Fibroblast growth factor; CKD: Chronic kidney disease.
Figure 8
Figure 8
The association between chronic kidney disease and coronary heart disease. Adapted from Hage FG 2009[67].

Similar articles

Cited by

References

    1. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351:1296–1305. - PubMed
    1. Ross L, Banerjee D. Cardiovascular complications of chronic kidney disease. Int J Clin Pract. 2013;67:4–5. - PubMed
    1. Soucie JM, McClellan WM. Early death in dialysis patients: risk factors and impact on incidence and mortality rates. J Am Soc Nephrol. 1996;7:2169–2175. - PubMed
    1. Bradbury BD, Fissell RB, Albert JM, Anthony MS, Critchlow CW, Pisoni RL, Port FK, Gillespie BW. Predictors of early mortality among incident US hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS) Clin J Am Soc Nephrol. 2007;2:89–99. - PubMed
    1. de Jager DJ, Grootendorst DC, Jager KJ, van Dijk PC, Tomas LM, Ansell D, Collart F, Finne P, Heaf JG, De Meester J, et al. Cardiovascular and noncardiovascular mortality among patients starting dialysis. JAMA. 2009;302:1782–1789. - PubMed

LinkOut - more resources